XWELL, Inc. (NASDAQ:XWEL) Short Interest Down 78.7% in March

XWELL, Inc. (NASDAQ:XWEL) was the recipient of a large decrease in short interest in the month of March. As of March 13th, there was short interest totaling 527,181 shares, a decrease of 78.7% from the February 26th total of 2,476,054 shares. Based on an average daily volume of 1,692,311 shares, the short-interest ratio is currently 0.3 days. Approximately 10.6% of the shares of the company are short sold.

Wall Street Analyst Weigh In

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of XWELL in a research report on Wednesday, January 21st. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat, the stock currently has a consensus rating of “Sell”.

XWELL Trading Up 0.8%

Shares of XWEL stock opened at $1.29 on Friday. The stock has a 50 day moving average of $0.82 and a two-hundred day moving average of $0.83. XWELL has a 12 month low of $0.26 and a 12 month high of $2.20. The company has a market capitalization of $7.44 million, a P/E ratio of -0.38 and a beta of 0.87.

XWELL Company Profile

XWELL, Inc provides health and wellness services in airport and off airport marketplaces in the United States and internationally. It operates in four segments: XpresSpa, XpresTest, Naples Wax Center, and Treat. The XpresSpa segment traveler's spa services, including massage, nail, and skin care services, as well as spa and travel products. The XpresTest segment offers diagnostic COVID-19 tests at XpresCheck Wellness Centers in airports, to airport employees and to the traveling public but has transitioned to the CDC's bio-surveillance program; and provides marketing support through HyperPointe business to various health and health-related channels.